AI discovery platforms replacing human-led research programs
#1Platforms like Isomorphic Labs (DeepMind spinoff), Recursion Pharmaceuticals, Insilico Medicine, and Absci are running AI-driven drug discovery pipelines that go from target identification to lead optimization with minimal human molecular biologist involvement. AlphaFold 3 now predicts protein-ligand, protein-DNA, and protein-RNA interactions, not just protein structure. Recursion's platform screens millions of perturbations computationally before any wet-lab validation.